Home » Topics » Regulatory » Patents

Patents
RSS

Synaptic develops selective human alpha1A-receptor antagonists

Feb. 2, 1998

Roche discloses inhibitors of bacterial dihydrofolate reductase

Feb. 2, 1998

Vitamin D3 analogues from Roche for skin, neoplastic diseases

Feb. 2, 1998

BMS prepares MTP inhibitors for atherosclerosis and related diseases

Feb. 2, 1998

Roche patents vitamin D analogues for osteoporosis

Jan. 30, 1998

New antifungals reported by J&J subsidiary

Jan. 30, 1998

Vitamin D analogues disclosed by Roche for hyperproliferative disorders

Jan. 30, 1998

Diosmetin derivatives for vascular disorders prepared at ADIR

Jan. 30, 1998

Novel chemokine identified and characterized at Millennium

Jan. 30, 1998

Lilly patents new voltage-sensitive calcium channel antagonists for CNS disorders

Jan. 30, 1998

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 31, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 31, 2025.
Researchers discover how glioblastoma tumors dodge chemotherapy
BioWorld MedTech
Researchers at the University of Sydney have uncovered a mechanism that may explain why glioblastoma returns after treatment, and the world-first discovery offers...
Shionogi nabs revenue-generating ALS drugs with $2.5B Tanabe pact
BioWorld
Shionogi & Co. Ltd. will acquire global rights to U.S. FDA approved amyotrophic lateral sclerosis therapy edaravone through a $2.5 billion acquisition deal with...
Big pharma taps fast Asia innovation in search of next Keytruda
BioWorld
Speed and innovation from Asia Pacific’s (APAC) biotechnology sector had big pharma scouring the region for the next oncology heir to Keytruda (pembrolizumab),...